SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120) (AVTX) — Jun 7, 2017

Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)
Date: June 7, 2017 · CIK: 0001534120 · Accession: 0001628280-17-006265

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-218252

Date
June 7, 2017
Author
Not clearly detected
Form
CORRESP
Company
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)

Letter

Document

June 7, 2017

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Healthcare & Insurance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Jeffrey Gabor

Re: Cerecor Inc.

Registration Statement on Form S-3

File No. 333-218252

Acceleration Request

Requested Date: Friday, June 9, 2017

Requested Time: 4:30 P.M. Eastern Standard Time

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-218252) (the “Registration Statement”) to become effective on Friday, June 9, 2017, at 4:30 p.m. Eastern Standard Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “Staff”).

Once the Registration Statement has been declared effective, please orally confirm that event with Brent B. Siler of Cooley LLP, counsel to the Registrant, at (202) 728-7040, or in his absence, Madison Jones at (202) 728-7087.

[Signature page follows]

Very truly yours,
Cerecor Inc.

Show Raw Text
CORRESP
1
filename1.htm

		Document

June 7, 2017

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Healthcare & Insurance

100 F Street, N.E.

Washington, D.C. 20549

Attn:    Jeffrey Gabor

Re:    Cerecor Inc.

Registration Statement on Form S-3

File No. 333-218252

Acceleration Request

Requested Date:    Friday, June 9, 2017

Requested Time:    4:30 P.M. Eastern Standard Time

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-218252) (the “Registration Statement”) to become effective on Friday, June 9, 2017, at 4:30 p.m. Eastern Standard Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “Staff”).

Once the Registration Statement has been declared effective, please orally confirm that event with Brent B. Siler of Cooley LLP, counsel to the Registrant, at (202) 728-7040, or in his absence, Madison Jones at (202) 728-7087.

[Signature page follows]

Very truly yours,

Cerecor Inc.

By: /s/ Mariam E. Morris

Mariam E. Morris

Chief Financial Officer

cc:    Uli Hacksell, Ph.D., Cerecor Inc.

Brent B. Siler, Cooley LLP